Evaluation of the Efficacy and Safety of the Dermal Filler for Augmentation of Labia Majora.

NACompletedINTERVENTIONAL
Enrollment

35

Participants

Timeline

Start Date

November 11, 2019

Primary Completion Date

July 12, 2020

Study Completion Date

August 26, 2020

Conditions
Labia Majora Atrophy and Hypotrophy
Interventions
DEVICE

MMI-22-04-2019

A cross-linked form of the Hyaluronic Acid is used in intradermal injection to augment the labia majora area.

Trial Locations (1)

1592

Medical Centre Ramus, Sofia

All Listed Sponsors
lead

Mesoestetic Pharma Group S.L.

INDUSTRY

NCT04652817 - Evaluation of the Efficacy and Safety of the Dermal Filler for Augmentation of Labia Majora. | Biotech Hunter | Biotech Hunter